Read more
This bookgathers perspectives from across Asia into one place, allowing for effective advocacy. It offers a single source of material that can be used by health professionals in East and Southeast Asia on drug policy and explains recent changes towards harm reduction and treatment modalities to the general public in East and Southeast Asia.
List of contents
Foreword
Introduction
Chapter 3: Historical Perspectives of Drug Use in Asia
Chapter 4: Harm Reduction is Good Public Health
Chapter 5: Human Rights and Drug Policy
Chapter 6: Drug Users and Imprisonment
Chapter 7: Law Enforcement and Drug Policy in Southeast Asia
Chapter 8: Effective Development and Effective Drug Control are Interdependent: the example of Southeast Asia
Chapter 9: Illicit drug policy in Southeast Asia - The Users' Perspective
Chapter 10: Harm Reduction: The Islamic Perspective
Chapter 11: HIV and Hepatitis C Virus (HCV) Infection among People who Inject Drugs in East and Southeast Asia
Chapter 12: Unpacking Compulsory 'Rehabilitation' in Asia: Problems and Possible Solutions
Chapter 13: Responding to ATS use in East and Southeast Asia
Chapter 14: Case Study No. 1: Harm Reduction and Drug Policy in Thailand - One Step Forward, Two Steps Back
Chapter 15: Case Study No. 2: Drug Policy in Taiwan
Chapter 16: Case Study No. 3: Emerging from a Black Box: Drug Policymaking in Vietnam
Chapter 17: Case Study No. 4: Drug Policy in China
Chapter 18: Case Study No. 5: Compulsory Drug Rehabilitation in China
Chapter 19: Alternatives to Criminal Justice: Drug Courts, Drug Diversion, and Decriminalisation
Chapter 20: Capital Punishment for Drug Offences
Chapter 21: Drug Treatment Across Asia
Chapter 22: The Way Forward
About the author
Fifa Rahman is policy manager at the Malaysian AIDS Council.
Nick Crofts is director of the Centre for Law Enforcement and Public Health.
Summary
This book gathers perspectives from across Asia into one place, allowing for effective advocacy. It offers a single source of material that can be used by health professionals in East and Southeast Asia on drug policy and explains recent changes towards harm reduction and treatment modalities to the general public in East and Southeast Asia.
